TP53 and breast carcinoma: MiR-150-5p also presented the highest number of associations with the clinical parameters analyzed; its down-regulation was associated with larger tumor size, high expression levels of the p53 protein, increased breast cancer recurrence, presence of distant metastasis, and patients’ deceased status.